Nucleic Acids Research, 2002, Vol. 30, No. 16 3602-3608
© 2002 Oxford University Press
Imprinting regulator DNMT3L is a transcriptional repressor associated with histone deacetylase activity
Institute of Medical Technology and Department of Pathology, Tampere University Hospital, University of Tampere, FIN-33014 Tampere, Finland
*To whom correspondence should be addressed. Tel: +358 3 215 7754; Fax: +358 3 215 7710; Email: part.peterson{at}uta.fi
Received April 2, 2002; Revised and Accepted June 26, 2002
| ABSTRACT |
|---|
|
|
|---|
DNMT3L is a regulator of imprint establishment of normally methylated maternal genomic sequences. DNMT3L shows high similarity to the de novo DNA methyltransferases, DNMT3A and DNMT3B, however, the amino acid residues needed for DNA cytosine methyltransferase activity have been lost from the DNMT3L protein sequence. Apart from methyltransferase activity, Dnmt3a and Dnmt3b serve as transcriptional repressors associating with histone deacetylase (HDAC) activity. Here we show that DNMT3L can also repress transcription by binding directly to HDAC1 protein. We have identified the PHD-like zinc finger of the ATRX domain as a main repression motif of DNMT3L, through which DNMT3L recruits the HDAC activity needed for transcriptional silencing. Furthermore, we show that DNMT3L protein contains an active nuclear localisation signal at amino acids 156159. These results describe DNMT3L as a co-repressor protein and suggest that a transcriptionally repressed chromatin organisation through HDAC activity is needed for establishment of genomic imprints.
| INTRODUCTION |
|---|
|
|
|---|
In genomic imprinting one of the two alleles of an autosomal gene is silenced epigenetically depending on their parental origin. Evidently, imprinting is controlled by several consequent and inter-dependent cis-acting mechanisms that regulate the chromatin structure (1). The critical role in transmitting the imprinting signals is the chromatin methylation pattern, which in mammals is established predominantly at cytosine nucleotides within CpG islands (2). Aberrant changes in DNA methylation profiles are common features of cancer and cause developmental abnormalities (36). Examples are imprinting disorders like Prader-Willi and Angelman syndromes, which result from altered methylation on human chromosome 15q11q13 (7,8).
The molecular basis of methylation-mediated gene regulation is related to changes in chromatin folding. The dynamic changes of chromatin are regulated by histone N-terminal modifications determining the transcriptionally active or repressed chromatin state (reviewed in 9). Direct connection between methylation of DNA and transcriptional repression is mediated via binding of methylated cytosine-binding protein MeCP2 to methyl-CpG dinucleotides and formation of a complex with histone deacetylase (HDAC) (10,11). In this way, the methylation pattern represents epigenetic marking leading to transcriptional silencing through chromatin remodelling.
We have recently isolated a novel DNA-cytosine 5-methyltransferase-like gene (DNMT3L) on chromosome 21q22.3 (12). The DNMT3L protein shows high similarity to human and mouse DNA-cytosine 5-methyltransferase 3 family (DNMT3) members (13,14), proteins involved in de novo methylation of CpG dinucleotide sequences in genome. In addition to DNMT3L, four DNMTs have been characterised altogether, of which three, DNMT1 (15), DNMT3A and DNMT3B (3), have been demonstrated to have cytosine methyltransferase activity. Like all DNMT3 family members, DNMT3L shares similarity with ATRX protein (16,17) in its cysteine-rich zinc finger motif region. Dnmt3a and Dnm3b are essential for de novo methylation and for normal mouse development (3). The two proteins exhibit non-overlapping function in development and produce a methylation pattern that is not random and rather reflects specific DNA targets (3,18). Binding of DNMT proteins to DNA, however, has little dependence on sequence context and, therefore, de novo methylation has been proposed to be under the control of regulatory factors that interact with methyltransferases and mediate the DNA binding specificity (19). As an indication of this, Dnmt3a has been demonstrated to associate, like other co-repressors, with HDAC1 and with transcription factor RP58 (20). These interacting partners identify Dnmt3a as a co-repressor protein carrying deacetylase activity which is targeted to regulatory foci via DNA-binding transcription factors.
Recently, Bourchis et al. (21) generated a targeted disruption of the Dnmt3l gene in mouse in which male testes had severe hypogonadism and a Sertoli cell only phenotype with azoospermia. The heterozygous progeny of the Dnmt3l-deficient homozygous females failed to develop past 9.5 days due to embryonic defects resulting in biallelic expression of genes that are normally expressed only from the allele of paternal origin. The authors concluded that Dnmt3l is required specifically for the establishment of maternal genomic imprints and it is essential for the de novo methylation of single copy DNA sequences. As the Dnmt3l protein sequence lacks the catalytic motifs needed for methyltransferase activity, it is likely to function as a regulator of methylation at imprinted loci rather than a DNA cytosine methyltransferase.
The mechanism by which Dnmt3l is involved in establishing genomic imprints in the germline has remained unknown. Here we show that DNMT3L can mediate transcriptional repression and that the repression is mediated through interaction with HDAC protein and its activity. These results indicate that the mechanisms to establish genomic imprints may employ histone deacetylation-mediated repression processes and suggest that other DNA-binding regulatory factors are needed to mediate specific de novo methylation of single copy DNA sequences.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Plasmids
To create the different DNMT3L constructs used in the CAT assay DNMT3L fragments DNMT3L 184 (nucleotides 482736), DNMT3L 4584 (nucleotides 617736) and DNMT3L 88153 (nucleotides 746943) were amplified by PCR and cloned into the pM vector (Clontech) EcoRI and SalI sites downstream of the Gal4 DNA-binding domain (Gal4DB). pM-DNMT3L 1195 (nucleotides 4821069), pM-DNMT3L (nucleotides 4821651) and pM-DNMT3L 164387 (nucleotides 9741651) were constructed by digesting the pcDNMT3L 1195, pcDNMT3L and pGEX-DNMT3L vectors, respectively, with EcoRI and HindIII restriction enzymes and subcloning the fragments into pM vector. DNMT3L 88387 (nucleotides 7461651) was cloned into pM vector by PCR using primers with EcoRI and HindIII sites. To create plasmids pcDNMT3L 1195 and pcDNMT3L, which encode N-terminal and full-length myc epitope-tagged DNMT3L, nucleotides 4821069 (amino acids 1195) and 4821651 (amino acids 1387) were amplified by PCR and cloned between the pcDNA3.1 vector (Invitrogen) EcoRI and HindIII sites. pING14AHDAC1 and GSTHDAC1 were generous gifts from Drs G. Akusjärvi and T. Punga (University of Uppsala). pcHDAC1 with an anti-Flag tag was kindly provided by Dr T. Kouzarides (University of Cambridge). Different GSTDNMT3L fragments (GSTDNMT3L 184, GSTDNMT3L 4584, GSTDNMT3L 88153, GSTDNMT3L 1195, GST DNMT3L 88387 and GSTDNMT3L) used for GST pull-down assays were digested out from corresponding pM- or pcDNMT3L vectors and subcloned downstream of the glutathione S-transferase (GST) gene into the pGEX-1
T vector between EcoRI and XhoI or HindIII sites. GSTDNMT3L 164387 was amplified by PCR and cloned into the pGEX-1
T vector between EcoRI and XhoI sites. The pGEX-1
T vector, which contains a modified multiple cloning site, was a gift from Dr K. Saksela (IMT, University of Tampere). To construct plasmids pGFP-NLS and pGFP-DNMT3L for immunofluorescence, DNMT3L nucleotides 9061005 (amino acids 142173) and 4821651 (amino acids 1387) were amplified by PCR and cloned downstream of green fluorescent protein between the pEGFP-C3 vector (Clontech) EcoRI and SalI sites. All PCR cloned constructs were verified by sequencing.
Cell cultures
Human rhabdomyosarcoma (RD) cells (American Type Culture Collection) and Cos-7 cells were cultured in Dulbeccos modified Eagles medium supplemented with 10% foetal calf serum and antibiotics. THP-1 cells were grown in RPMI 1640 supplemented with 10% foetal calf serum, 2 mM L-glutamine and antibiotics. All media and supplements were obtained from Bio Whittaker Europe.
CAT assay
Aliquots of 3 x 105 RD cells were transiently transfected with 500 ng pM, pM-DNMT3L 1195, pM-DNMT3L 88387, pM-DNMT3L 164387, pM-DNMT3L 184, pM-DNMT3L 4584, pM-DNMT3L 88153 or full-length pM-DNMT3L 1387 together with 1 µg Gal4TKCAT reporter (kindly provided by Dr Y. Shi, Harvard Medical School) using Lipofectamine (Life Technologies) according to the manufacturers instructions. Forty-six hours after transfection cells were washed twice with ice-cold phosphate-buffered saline (PBS) and lysed with the CAT ELISA kit (Roche) lysis buffer for 20 min at 4°C. The CAT activity assay was performed using a CAT ELISA kit (Roche) according to the manufacturers protocol. For the dose-dependence study 1 µg Gal4TKCAT reporter gene was co-transfected with 200 ng or 1 µg pM-DNMT3L 1195 as mentioned above. Trichostatin A (TSA) treatment was performed with RD cells co-transfected with 1 µg Gal4TKCAT reporter and 500 ng pM-DNMT3L 1195. At 22 h after transfection 100 nM TSA (Sigma) was added for 24 h. All CAT assay transfections were performed as duplicates and normalised against total protein. CAT activity of the pM-vector with a Gal4DB without a fusion partner was set to 100%.
HDAC1 GST pull-down assays
In vitro translation of pcDNMT3L 1195 and pING14AHDAC was performed using the TNT Coupled Reticulocyte Lysate System (Promega) according to the manufacturers instructions. GST fusion proteins were purified as described by Frangioni and Neel (22) from 200 ml of 1 mM IPTG-induced Escherichia coli XL-1 Blue culture. Twenty microlitres of purified GST fusion proteins (total volume of purified GST protein/bead slurry was 300 µl) and 2.5 µl in vitro translation products (50 µl) were used for in vitro binding assay that was performed as described elsewhere (23). Bound proteins were separated by SDSPAGE and subjected to autoradiography. For GST pull-down from RD cell lysate 24 µg Flag epitope-tagged pcHDAC1 was transiently transfected into 2 x 106 RD cells using ExGen500 in vitro transfection reagent (MBI Fermentas) according to the manufacturers protocol. After 48 h cells were lysed by freezing and thawing in 1 ml of NET0.2 lysis buffer (50 mM TrisHCl pH 7.5, 150 mM NaCl, 5 mM EDTA, 2 µg/ml aprotinin, 500 ng/ml leupeptin). Lysates were passed five times through a 19G needle and centrifuged at 14 000 g at 4°C for 20 min. Equivalent amounts of GST, GSTDNMT3L 1195 and GSTDNMT3L proteins were incubated with pcHDAC1 lysate in blocking buffer (5% milk, 1% BSA in PBS) at 4°C for 1 h. Pull-down products were washed once with PBS, 0.5% NP-40 and twice with PBS. Bound proteins were separated by SDSPAGE and HDAC1/DNMT3L interaction was detected by western blotting with anti-Flag antibody (M2 clone; Sigma).
Histone deacetylation activity assay
THP-1 monocytes were lysed in NET0.2 buffer for 20 min on ice and the protein concentration of total protein lysate was measured using a Bio-Rad DC Protein Assay Kit. HDAC1 immunoprecipitations were done by incubating 1 µg anti-HDAC1 and anti-GAL4 antibodies (H-51 and RK5C1; Santa Cruz) with 1 mg total THP-1 extract in blocking solution (5% milk, 1% BSA in PBS) at 4°C. After 12 h protein ASepharose beads (Amersham Pharmacia Biotech) were added to immunoprecipitation samples and incubation was continued for 12 h at 4°C. HDAC1 GST pull-downs were performed by incubating different GSTDNMT3L constructs attached to glutathioneSepharose with 1 mg total THP-1 extract in blocking solution (5% milk, 1% BSA in PBS) for 24 h at 4°C. Protein ASepharose and GSTSepharose beads were washed three times with NET0.2 buffer and once with HDAC10 buffer (10 mM TrisHCl pH 8.0, 10 mM NaCl, 10% glycerol). Finally, Sepharose beads and the attached proteins were resuspended in 40 µl of HDAC10 buffer and used for the histone deacetylation assay, which was performed using a Histone Deacetylation Assay Kit (histone H4 peptide substrate; Upstate Biotechnology). The assay was carried out according to the manufacturers protocol with the following exceptions: 50 000 c.p.m. of labelled peptide was used instead of 20 000 c.p.m. and HDAC10 buffer was used instead of the HDAC buffer supplied with the kit.
Immunofluorescence studies
Aliquots of 1 x 105 Cos-7 cells were grown on coverslips in 6-well plates and transfected with 1 µg plasmid pEGFP-C3, pGFP-NLS or pGFP-DNMT3L using ExGen500 transfection reagent (MBI, Fermentas) according to the instructions provided by the manufacturer. After 48 h cells were fixed with 4% paraformaldehyde and immunofluorescence data were acquired using an Olympus IX70 microscope. Images were captured with a digital CCD camera (Wallac) and UltraVIEW v.4.0.15 software for the PC.
| RESULTS |
|---|
|
|
|---|
DNMT3L can repress transcription through the PHD-like zinc finger of the ATRX domain
Dnmt3a and Dnmt3b have been shown to have the ability to repress transcription (20,24), so we wanted to test whether DNMT3L could act as a transcriptional co-repressor as well. In our system a DNMT3L construct was fused to the Gal4DB of the pM vector (pM-DNMT3L) and co-transfected into RD cells together with a CAT reporter gene that contained Gal4-binding sites upstream of a strong thymidine kinase promoter. Co-transfection repressed the reporter activity by
30% when compared with empty pM vector, indicating that DNMT3L indeed has co-repressor activity. We further constructed several DNMT3L truncation constructs in order to identify the protein domain responsible for the repressional effect (Fig. 1A). Transfection of the reporter constructs pM-DNMT3L 1195, pM-DNMT3L 88387, pM-DNMT3L 184 and pM-DNMT3L 164387 showed that the repressional activity was largely mediated through the PHD-like zinc finger of the ATRX domain, as pM-DNMT3L 1195 inhibited transcriptional activity by up to 80% and the strongest repression (90%) was observed with the fragment pM-DNMT3L 88387, which contains the C-terminal region of the protein with the PHD-like zinc finger but not the C2C2 part of the ATRX domain. Less transcriptional repression (60%) than with PHD-containing fragments was also found with the pM-DNMT3L 164387 fragment, a C-terminal region without the PHD finger, suggesting that the C-terminal part may contain another repressional region (Fig. 1B).
|
To further dissect the role of the ATRX domain in repression we used a construct with the N-terminal region of DNMT3L with the C2C2 domain but lacking the PHD-like finger (pM-DNMT3L 184). Interestingly enough, this fragment did not have repressional activity and was even able to slightly activate the Gal4 system (Fig. 1B). Experiments with only the C2C2 (pM-DNMT3L 4584) and PHD (pM-DNMT3L 88153) fragments, however, gave similar results to empty pM vector, which might be due to the fact that these shorter fragments covered only a minimal domain and did not fold correctly.
Taken together these results demonstrate that DNMT3L has a repressional activity, which is predominantly mediated by the PHD-like zinc finger of ATRX as a strong repressional domain.
DNMT3L repression is dose-dependent and inhibited by TSA
After finding that the PHD-like zinc finger of the ATRX domain was responsible for transcriptional repression by DNMT3L, we next wanted to determine whether the repression was dependent on dosage of the DNMT3L protein fragment containing the repression domain. Increasing amounts of pM-DNMT3L 1195 repressed the CAT activity in a dose-dependent manner, as increasing the DNA construct concentration from 200 ng to 1 µg decreased the activity 4-fold (Fig. 1C). Since HDAC activity is related to transcriptional repression and as the repression of many proteins has been shown to be mediated by HDAC activity, we further tested whether the repression activity in our system was dependent on a HDAC-specific inhibitor, TSA. Addition of 100 nM TSA to pM-DNMT3L 1195-transfected cells increased the CAT activity to a comparable level with empty pM vector, suggesting that the DNMT3L repression is HDAC-dependent (Fig. 1D).
DNMT3L interacts with HDAC1
Previously, it has been shown that DNMT1 can repress transcription through directly interacting with HDAC1 (23). More recently, it was shown that by using its zinc finger domain for association with HDAC1, Dnmt3a can also act as a transcriptional repressor (20). With this data, we asked whether DNMT3L could use its ATRX region for physical interaction with HDAC1. We performed in vitro GST pull-down assays using GSTDNMT3L 1195 and in vitro translated full-length HDAC1. Figure 2A shows that a GSTATRX domain fusion interacted with HDAC1 whereas GST alone did not. To test the same interaction in the opposite way, we used a GSTHDAC1 protein in pull-down assays with in vitro translated ATRX domain. As again seen in Figure 2B, interaction of the ATRX domain was present with HDAC1 but not with GST protein alone. To prove even further that DNMT3L associates with HDAC1, we performed GST pull-down assays with GSTDNMT3L 1195 and GSTDNMT3L 1387 using a lysate of RD cells transfected with pcHDAC1. Figure 2C shows that both full-length GSTDNMT3L and GSTDNMT3L 1195 interact with HDAC1 as detected by western blotting against HDAC1 protein. These results indicate that DNMT3L, similarly to Dnmt3a, can physically interact with HDAC1 protein using its zinc finger ATRX region for interaction.
|
DNMT3L associates with HDAC activity
After showing an interaction between DNMT3L and HDAC1, we next studied whether DNMT3L binding to HDAC1 is associated with the enzymatically active deacetylase. To test this, we used THP-1 total protein lysate as a HDAC1 source and performed GST pull-down assays with seven different DNMT3L fragments (Fig. 1A) fused to GST protein. As positive and negative controls, anti-HDAC1 and anti-GAL4 antibodies, respectively, were used in immunoprecipitations. The pull-down products and precipitates were incubated with 3H-acetylated peptide substrate and deacetylation was measured as released [3H]acetate using a scintillation counter. Positive control immunoprecipitations with anti-HDAC1 antibody efficiently precipitated HDAC activity and negative control antibody to GAL4 gave background activity (Fig. 3). Of the seven different GSTDNMT3L fusion proteins used in the assay, all those fragments that contained the PHD-like zinc finger of the ATRX domain were able to pull down the HDAC activity from THP-1 lysate. GSTDNMT3L 1195, 1387, 88153 and 88387 fusion proteins consistently associated with HDAC activity in three separate experiments, whereas GSTDNMT3L 164387, 164, and 4564 (without the PHD finger) and GST alone did not show deacetylase activity in the assay (Fig. 3). The highest HDAC activity was repeatedly seen with the DNMT3L 88387 fusion protein containing the C-terminal part of the protein in addition to the PHD-like zinc finger domain of the ATRX region. To further verify the enzymatic reaction of HDAC and to show that a deacetylase inhibitor could relieve HDAC activity, we used 100 mM sodium butyrate, similar to TSA, which was added to inhibit the deacetylase reaction. As seen in Figure 3, deacetylase activity associated with all four DNMT3L fragments containing the PHD domain was inhibited by sodium butyrate treatment. These results demonstrate that DNMT3L associated with HDAC1 has functional deacetylase activity and that the PHD-like zinc finger of the ATRX domain is needed for enzymatic reactivity.
|
DNMT3L contains an active nuclear localisation signal (NLS)
We have previously observed that in transiently transfected Cos-1 and RD cells both human and mouse DNMT3L proteins subcellularly localise in the cytoplasm and nucleus. Thus, examination of the DNMT3L sequence revealed a possible NLS, RRRK, at amino acids 156159. We cloned DNMT3L nucleotides 9061005 (amino acids 142173) downstream of green fluorescent protein into pEGFP-C3 vector and transiently transfected the construct into Cos-7 cells. The GFPNLS 142173 protein fragment localised to the nucleus (Fig. 4A), demonstrating that DNMT3L has a functional NLS, while GFPDNMT3L and GFP alone were distributed in the cytoplasm and nucleus (Fig. 4B and C).
|
| DISCUSSION |
|---|
|
|
|---|
In this study we report experiments identifying DNMT3L protein as a transcriptional co-repressor. Previously it has been shown that the function of methyltransferase proteins includes actions as repressors. The major enzyme responsible for maintenance of DNA methylation, DNMT1, establishes a repressive transcription complex by interacting with HDAC1 (23) and HDAC2 (25). A further connection between methyltransferases and gene silencing comes from experiments showing that the de novo methyltransferases Dnmt3a and Dnmt3b repress transcription in association with HDAC activity (20,24). Interestingly, in this context, Dnmt3a and Dnmt3b have been shown to repress in a manner that does not require its de novo methyltransferase activity. Previously we isolated the human and mouse DNMT3L genes (12,26) and sequence analysis of the two homologous proteins pointed to a lack of amino acid residues needed for methyltransferase activity. Although sharing significant similarity with the conserved motifs I, IV and VI found in the catabolic domain of other DNMT family proteins (2729), the absence of the critical residues implied that DNMT3L/Dnmt3l protein has no direct methyltransferase activity and functions through other mechanisms. Our current results, showing a transcriptional repression effect of DNMT3L mediated through interaction with HDAC and its activity, support similar findings observed with Dnmt3a.
The majority of the repression effect can be attributed to the ATRX domain of DNMT3L protein. The ATRX domain connected with the N-terminal part of DNMT3L protein was able to more actively repress transcription than full-length DNMT3L protein, decreasing CAT activity to 20% of that in the presence of the pM vector, and in some experiments a reduction was observed to as low as 11%. These results are consistent with recent observations by Fuks et al. (20) and Bachman et al. (24) on other DNMT3 family members, which demonstrated that the repressional activity of Dnmt3a and Dnmt3b was mediated through their ATRX-like regions. To further scrutinise the repression activity of the ATRX-like domain we analysed the C2C2 region in the context of the N-terminal part and the PHD-like finger in the context of the C-terminal region of DNMT3L separately. Repression was still observed with the fragment with the PHD-like finger whereas the N-terminal part even exhibited a slight activation effect. This result may explain the discrepancy in repression activity found between the ATRX domain-containing fragment and full-length protein. In addition, we have demonstrated that the ATRX domain was able to directly interact with HDAC1 and, in concordance with this, associates with HDAC activity. Again, of seven tested constructs the four fragments with the PHD-like finger of the ATRX region gave consistent effects on deacetylase enzymatic activity, thus highlighting the role of this domain in functional repression. Moreover, in both repression and deacetylation assays the PHD-like zinc finger showed the most remarkable effect in the context of the C-terminal region of DNMT3L.
Our previous studies showed that DNMT3L subcellularly localises in the nucleus and cytoplasm. In this study we identified a functional NLS, RRRK, at DNMT3L amino acids 156159. Bachmann et al. (24) showed that in transient transfections of NIH 3T3 cells, Dnmt3a is localised to discrete nuclear foci representing pericentric heterochromatin and that the ATRX-like domain of Dnmt3a was not needed for targeting of the protein. However, alignment of all three DNMT3 family members suggests that the same NLS is also present in DNMT3A and DNMT3B. Whether the NLS identified here in DNMT3L is also functional in DNMT3A and DNMT3B remains to be studied.
In conclusion, our major findings provide information that despite the lack of methyltransferase activity DNMT3L can act as a co-repressor by interacting with HDAC1 through its ATRX-like domain and associates with HDAC activity. These results also indirectly suggest that to regulate the establishment of genomic imprints in sperm and oocytes, DNMT3L may make use of nucleosome deacetylase-linked processes or recruit, through an HDAC complex, active de novo methyltransferases such as DNMT3A or DNMT3B. Lack of obvious DNA-binding domains in the DNMT3L sequence also points to the possibility that DNMT3L, like Dnmt3a, may interact with specific DNA-binding transcription factors.
| ACKNOWLEDGEMENTS |
|---|
We thank U. Kiiskinen for excellent technical assistance. This work was supported by the Academy of Finland, Sigrid Juselius Foundation and Medical Research Fund of Tampere University Hospital.
| REFERENCES |
|---|
|
|
|---|
- Ferguson-Smith,A.C. and Surani,M.A. (2001) Imprinting and the epigenetic asymmetry between parental genomes. Science, 293, 10861089.
[Abstract/Free Full Text] - Paulsen,M. and Ferguson-Smith,A.C. (2001) DNA methylation in genomic imprinting, development and disease. J. Pathol., 95, 97110.
- Okano,M., Bell,D.W., Haber,D.A. and Li,E. (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell, 99, 247257.[ISI][Medline]
- Xu,G.L., Bestor,T.H., Bourchis,D., Hsieh,C.L., Tommerup,N., Bugge,M., Hulten,M., Qu,X., Russo,J.J. and Viegas-Pequignot,E. (1999) Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature, 402, 187191.[Medline]
- Amir,R.E., Van den Veyver,I.B., Wan,M., Tran,C.Q., Francke,U. and Zoghbi,H.Y. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genet., 23, 185188.[ISI][Medline]
- Rountree,M.R, Bachman,K.E, Herman,J.G. and Baylin,S.B. (2001) DNA methylation, chromatin inheritance and cancer. Oncogene, 20, 31563165.[ISI][Medline]
- Knoll,J.H., Nicholls,R.D., Magenis,R.E., Graham,J.M., Lalande,M. and Latt,S.A. (1989) Angelman and Prader-Willi syndromes share common chromosome 15 deletion but differ in parental origin of the deletion. Am. J. Med. Genet., 32, 285290.[ISI][Medline]
- Nicholls,R.D. and Knepper,J.L. (2001) Genome organization, function and imprinting in Prader-Willi and Angelman syndromes. Annu. Rev. Genomics Hum. Genet., 2, 153175.
- Jenuwein,T. and Allis,D.C. (2001) Translating the histone code. Science, 293, 10741080.
[Abstract/Free Full Text] - Nan,X., Ng,H.H., Johnson,C.A., Laherty,C.D., Turner,B.M., Eisenman,R.N. and Bird,A. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393, 386389.[Medline]
- Ng,H.H. and Bird,A. (1999) DNA methylation and chromatin modification. Curr. Opin. Genet. Dev., 9, 158163.[ISI][Medline]
- Aapola,U., Shibuya,K., Scott,H.S., Ollila,J., Vihinen,M., Heino,M., Shintani,A., Kawasaki,K., Minoshima,S., Krohn,K., Antonarakis,S.E., Shimizu,N., Kudoh,J. and Peterson,P. (2000) Isolation and initial characterization of a novel zinc finger gene, DNMT3L, on 21q22.3, related to the cytosine-5-methyltransferase 3 gene family. Genomics, 65, 293298.[ISI][Medline]
- Okano,M., Xie,S. and Li,E. (1998) Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genet., 19, 219220.[ISI][Medline]
- Xie,S., Wang,Z., Okano,M., Nogami,M., Li,Y., He,W.W., Okumura,K. and Li,E. (1999) Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene, 236, 8795.[ISI][Medline]
- Bestor,T., Laudano,A., Mattaliano,R. and Ingram,V. (1988) Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzyme is related to bacterial restriction methyltransferases. J. Mol. Biol., 203, 971983.[ISI][Medline]
- Gibbons,R.J., Picketts,D.J., Villard,L. and Higgs,D.R. (1995) Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome). Cell, 80, 837845.[ISI][Medline]
- Gibbons,R.J., Bachoo,S., Picketts,D.J., Aftimos,S., Asenbauer,B., Bergoffen,J., Berry,S.A., Dahl,N., Fryer,A., Keppler,K., Kurosawa,K., Levin,M.L., Masuno,M., Neri,G., Peirpoint,M., Slaney,S.F. and Higgs,D.R. (1997) Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain. Nature Genet., 17, 146148.[ISI][Medline]
- Hsieh,C.-L. (1999) In vivo activity of murine de novo methyltransferases Dnmt3a and Dnmt3b. Mol. Cell. Biol., 19, 82118218.
[Abstract/Free Full Text] - Yoder,J.A., Soman,N.S., Verdine,G.L. and Bestor,T. (1997) DNA (cytosine-5) methyltransferases in mouse cells and tissues. Studies with a mechanism-based probe. J. Mol. Biol., 270, 385395.[ISI][Medline]
- Fuks,F., Burgers,W.A., Godin,N., Kasai,M. and Kouzarides,T. (2001) Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J., 20, 25362544.[ISI][Medline]
- Bourchis,D., Xu,G.L., Lin,C.S., Bollman,B. and Bestor,T.H. (2001) Dnmt3l and the establishment of maternal genomic imprints. Science, 294, 25362539.
[Abstract/Free Full Text] - Fragnioni,J.V. and Neel,B.G. (1993) Solibilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal. Biochem., 210, 179187.[ISI][Medline]
- Fuks,F., Burgers,W., Brehm,A., Hughes-Davies,L. and Kouzarides,T. (2000) DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nature Genet., 24, 8891.[ISI][Medline]
- Bachman,K.E., Rountree,M.R. and Baylin,S.B. (2001) Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J. Biol. Chem., 276, 3228232287.
[Abstract/Free Full Text] - Rountree,M.R., Bachman,K.E. and Baylin,S.B. (2000) DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nature Genet., 25, 269277.[ISI][Medline]
- Aapola,U., Lyle,R., Krohn,K., Antonarakis,S.E. and Peterson,P. (2001) Isolation and initial characterisation of the mouse Dnmt3l gene. Cytogenet. Cell Genet., 92, 122126.[ISI][Medline]
- Lauster,R., Trautner,T.A. and Noyer-Weidner,M. (1989) Cytosine-specific type II DNA methyltransferases. A conserved enzyme core with variable target-recognizing domains. J. Mol. Biol., 206, 305312.[ISI][Medline]
- Kumar,S., Cheng,X., Klimasauskas,S., Mi,S., Posfai,J., Roberts,R.J. and Wilson,G.G. (1994) The DNA (cytosine-5) methyltransferases. Nucleic Acids Res., 22, 110.
[Free Full Text] - Klimasauskas,S., Kumar,S., Roberts,R.J. and Cheng,X. (1994) HhaI methyltransferase flips its target base out of the DNA helix. Cell, 76, 357369.[ISI][Medline]
This article has been cited by other articles:
![]() |
J.-Y. Li, M.-T. Pu, R. Hirasawa, B.-Z. Li, Y.-N. Huang, R. Zeng, N.-H. Jing, T. Chen, E. Li, H. Sasaki, et al. Synergistic Function of DNA Methyltransferases Dnmt3a and Dnmt3b in the Methylation of Oct4 and Nanog Mol. Cell. Biol., December 15, 2007; 27(24): 8748 - 8759. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bai, K. Ghoshal, and S. T. Jacob Identification of T-cadherin as a Novel Target of DNA Methyltransferase 3B and Its Role in the Suppression of Nerve Growth Factor-mediated Neurite Outgrowth in PC12 Cells J. Biol. Chem., May 12, 2006; 281(19): 13604 - 13611. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Arnaud, K. Hata, M. Kaneda, E. Li, H. Sasaki, R. Feil, and G. Kelsey Stochastic imprinting in the progeny of Dnmt3L-/- females Hum. Mol. Genet., February 15, 2006; 15(4): 589 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gowher, K. Liebert, A. Hermann, G. Xu, and A. Jeltsch Mechanism of Stimulation of Catalytic Activity of Dnmt3A and Dnmt3B DNA-(cytosine-C5)-methyltransferases by Dnmt3L J. Biol. Chem., April 8, 2005; 280(14): 13341 - 13348. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Vasques, R. Stabellini, F. Xue, X. C. Tian, M. Soukoyan, and L. V. Pereira XIST Repression in the Absence of DNMT1 and DNMT3B DNA Res, January 1, 2005; 12(5): 373 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Suetake, F. Shinozaki, J. Miyagawa, H. Takeshima, and S. Tajima DNMT3L Stimulates the DNA Methylation Activity of Dnmt3a and Dnmt3b through a Direct Interaction J. Biol. Chem., June 25, 2004; 279(26): 27816 - 27823. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Kuan, P. Brewer-Jensen, and L. L. Searles Suppressor of sable, a Putative RNA-Processing Protein, Functions at the Level of Transcription Mol. Cell. Biol., May 1, 2004; 24(9): 3734 - 3746. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tzouanacou, S. Tweedie, and V. Wilson Identification of Jade1, a Gene Encoding a PHD Zinc Finger Protein, in a Gene Trap Mutagenesis Screen for Genes Involved in Anteroposterior Axis Development Mol. Cell. Biol., December 1, 2003; 23(23): 8553 - 8552. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu, P. Wang, C. A. Brown, C. A. Zilinski, and M. M. Matzuk Zygote Arrest 1 (Zar1) Is an Evolutionarily Conserved Gene Expressed in Vertebrate Ovaries Biol Reprod, September 1, 2003; 69(3): 861 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
M D Hodges, H C Rees, M J Seckl, E S Newlands, and R A Fisher Genetic refinement and physical mapping of a biparental complete hydatidiform mole locus on chromosome 19q13.4. J. Med. Genet., August 1, 2003; 40(8): e95 - 95. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



-HDAC1 and 





